Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Year-over-year net income growth rate
Latest
5.47%
↑ 157% vs avg
Percentile
P74
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-9.64%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 5.47% |
| Q3 2025 | -0.07% |
| Q2 2025 | 11.44% |
| Q1 2025 | 11.30% |
| Q4 2024 | 5.02% |
| Q3 2024 | 7.66% |
| Q2 2024 | -36.80% |
| Q1 2024 | 18.71% |
| Q4 2023 | -8.13% |
| Q3 2023 | 1.18% |
| Q2 2023 | -19.93% |
| Q1 2023 | 9.07% |
| Q4 2022 | -0.16% |
| Q3 2022 | -12.47% |
| Q2 2022 | 31.45% |
| Q1 2022 | -80.79% |
| Q4 2021 | -13.39% |
| Q3 2021 | -4.12% |
| Q2 2021 | -48.91% |
| Q1 2021 | -9.51% |
| Q4 2020 | -51.55% |
| Q3 2020 | 14.06% |
| Q2 2020 | -1.85% |
| Q1 2020 | -12.48% |
| Q4 2019 | -19.64% |
| Q3 2019 | 7.98% |
| Q2 2019 | -17.06% |
| Q1 2019 | -15.07% |
| Q4 2018 | 16.02% |
| Q3 2018 | -2.17% |
| Q2 2018 | -4.04% |
| Q1 2018 | 10.88% |
| Q4 2017 | -56.05% |
| Q3 2017 | 1.52% |
| Q2 2017 | -23.45% |
| Q1 2017 | -19.58% |
| Q4 2016 | -41.18% |
| Q3 2016 | -8.43% |
| Q2 2016 | -3.15% |
| Q1 2016 | -27.53% |